Literature DB >> 383031

The treatment of recurrent malignant pleural effusion.

E H Austin, M W Flye.   

Abstract

Effective control of a recurrent malignant pleural effusion can greatly improve the quality of life of the cancer patient. At least a dozen different techniques have been advocated for controlling this common complication of malignant disease. The present review collects and examines the clinical results of all techniques designed to treat this problem. The pathophysiology and diagnostic evaluation of the effusion are also discussed. On the basis of comparisons involving effectiveness, morbidity, and convenience, we recommend intrapleurally administered tetracycline with thoracostomy drainage as the technique of choice. Instillation of a talc suspension with thoracostomy drainage is also a safe and effective technique and should be employed when tetracycline fails or is contraindicated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383031     DOI: 10.1016/s0003-4975(10)63779-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Non-intubated video-assisted thoracic surgery as the modality of choice for treatment of recurrent pleural effusions.

Authors:  Solange E Cox; Mark R Katlic
Journal:  Ann Transl Med       Date:  2015-05

2.  Comparison of mitoxantrone and tetracycline as pleural sclerosing agents in rabbits.

Authors:  R W Light; N S Wang; J A Despars; S E Gruer; C Sassoon; F S Vargas
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.

Authors:  P Lissoni; S Barni; G Tancini; A Ardizzoia; E Tisi; M Angeli; A Rizzi
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

4.  Pleuro-peritoneal shunting. Alternative therapy for pleural effusions.

Authors:  A G Little; M H Kadowaki; M K Ferguson; V M Staszek; D B Skinner
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

5.  Parietal pleurectomy for malignant pleural effusion.

Authors:  W A Fry; J D Khandekar
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.